TW214553B - - Google Patents
Download PDFInfo
- Publication number
- TW214553B TW214553B TW081102729A TW81102729A TW214553B TW 214553 B TW214553 B TW 214553B TW 081102729 A TW081102729 A TW 081102729A TW 81102729 A TW81102729 A TW 81102729A TW 214553 B TW214553 B TW 214553B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- formula
- temperature
- ministry
- range
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68377091A | 1991-04-11 | 1991-04-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW214553B true TW214553B (enExample) | 1993-10-11 |
Family
ID=24745378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081102729A TW214553B (enExample) | 1991-04-11 | 1992-04-09 |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP0580812A1 (enExample) |
| JP (1) | JPH06503837A (enExample) |
| CA (1) | CA2108146A1 (enExample) |
| CZ (1) | CZ213693A3 (enExample) |
| FI (1) | FI934461L (enExample) |
| HU (1) | HUT70187A (enExample) |
| IE (1) | IE921148A1 (enExample) |
| IL (1) | IL101554A0 (enExample) |
| MX (1) | MX9201643A (enExample) |
| NO (1) | NO933611L (enExample) |
| NZ (1) | NZ242294A (enExample) |
| SK (1) | SK108293A3 (enExample) |
| TW (1) | TW214553B (enExample) |
| WO (1) | WO1992018507A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ245203A (en) * | 1991-11-29 | 1997-07-27 | Banyu Pharma Co Ltd | 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates |
| ES2136103T3 (es) * | 1992-06-22 | 1999-11-16 | Kyowa Hakko Kogyo Kk | Procedimiento para la preparacion de derivados de estaurosporina. |
| US5589472A (en) * | 1992-09-25 | 1996-12-31 | Vice; Susan F. | Diindolo compounds and pharmaceutical compositions containing them |
| US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
| US5723456A (en) * | 1993-12-07 | 1998-03-03 | Eli Lilly & Company | Therapeutic treatment for cardiovascular diseases |
| PL182124B1 (pl) * | 1993-12-07 | 2001-11-30 | Lilly Co Eli | Nowe zwiazki oraz srodek farmaceutyczny przeznaczony do leczenia powiklan cukrzycowych lub do leczenia nowotworów PL PL PL PL PL PL PL PL |
| US5843935A (en) * | 1993-12-07 | 1998-12-01 | Eli Lilly And Company | Protein kinase C inhibitors |
| AU1911095A (en) * | 1994-02-18 | 1995-09-04 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
| AU6657596A (en) * | 1995-07-31 | 1997-02-26 | Ciba-Geigy Ag | Trindene compounds |
| US20040037828A1 (en) * | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
| FR2826653B1 (fr) * | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TWI335221B (en) | 2001-09-27 | 2011-01-01 | Alcon Inc | Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| DK1651161T3 (da) | 2003-08-07 | 2012-01-30 | Healor Ltd | Farmaceutiske præparater og fremgangsmåder til at fremme sårheling |
| EP2452686A3 (en) | 2005-08-29 | 2012-09-05 | HealOr Ltd. | Methods and compositions for prevention and treatment of diabetic and aged skin |
| EP2181999A1 (en) | 2008-11-03 | 2010-05-05 | Zentiva, A.S. | Method of manufacturing ruboxistarin |
| EP2523677A2 (en) | 2010-01-11 | 2012-11-21 | Healor Ltd. | Method for treatment of inflammatory disease and disorder |
| EP3741375A1 (en) | 2014-07-17 | 2020-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for treating neuromuscular junction-related diseases |
| WO2016207366A1 (en) | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of viral infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923986A (en) * | 1987-03-09 | 1990-05-08 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of physiologically active substance K-252 |
| DE3924538A1 (de) * | 1989-07-25 | 1991-01-31 | Goedecke Ag | Indolocarbazol und dessen verwendung |
-
1992
- 1992-04-09 SK SK1082-93A patent/SK108293A3/sk unknown
- 1992-04-09 JP JP4510240A patent/JPH06503837A/ja active Pending
- 1992-04-09 EP EP92917468A patent/EP0580812A1/en active Pending
- 1992-04-09 HU HU9302869A patent/HUT70187A/hu unknown
- 1992-04-09 CZ CS932136A patent/CZ213693A3/cs unknown
- 1992-04-09 FI FI934461A patent/FI934461L/fi not_active Application Discontinuation
- 1992-04-09 MX MX9201643A patent/MX9201643A/es unknown
- 1992-04-09 IL IL101554A patent/IL101554A0/xx unknown
- 1992-04-09 EP EP92303187A patent/EP0508792A1/en not_active Withdrawn
- 1992-04-09 WO PCT/US1992/002661 patent/WO1992018507A1/en not_active Ceased
- 1992-04-09 CA CA002108146A patent/CA2108146A1/en not_active Abandoned
- 1992-04-09 NZ NZ242294A patent/NZ242294A/en unknown
- 1992-04-09 TW TW081102729A patent/TW214553B/zh active
- 1992-04-10 IE IE114892A patent/IE921148A1/en unknown
-
1993
- 1993-10-08 NO NO93933611A patent/NO933611L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06503837A (ja) | 1994-04-28 |
| HUT70187A (en) | 1995-09-28 |
| NZ242294A (en) | 1993-07-27 |
| NO933611D0 (no) | 1993-10-08 |
| CZ213693A3 (en) | 1994-05-18 |
| EP0580812A1 (en) | 1994-02-02 |
| AU1798292A (en) | 1992-11-17 |
| FI934461A0 (fi) | 1993-10-11 |
| WO1992018507A1 (en) | 1992-10-29 |
| IL101554A0 (en) | 1992-12-30 |
| EP0508792A1 (en) | 1992-10-14 |
| SK108293A3 (en) | 1994-09-07 |
| FI934461A7 (fi) | 1993-10-11 |
| NO933611L (no) | 1993-10-08 |
| IE921148A1 (en) | 1992-10-21 |
| CA2108146A1 (en) | 1992-10-12 |
| MX9201643A (es) | 1992-10-01 |
| HU9302869D0 (en) | 1993-12-28 |
| AU646163B2 (en) | 1994-02-10 |
| FI934461L (fi) | 1993-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6183198A (ja) | 新規アミノ酸化合物 | |
| US20220098152A1 (en) | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide | |
| JPS6317882A (ja) | ５−置換−１Ｈ−ピラゾロ〔３，４−ｂ〕ピラジン誘導体及び該化合物を含有する抗腫瘍剤 | |
| CN104557588B (zh) | 咖啡酸和阿魏酸的同二聚体,其制备方法及其药物组合物 | |
| CN110092808A (zh) | 一种甾醇化合物和药学上可接受的盐或前药及其应用 | |
| CN115677828B (zh) | 一种抗肿瘤的间二氯苯酚衍生物及其制备方法 | |
| JP2022553833A (ja) | エストロゲン受容体調節薬の塩及び形態 | |
| WO2023193563A1 (zh) | 一种噻吩并吡啶化合物的晶型a、制备方法及其药物组合物 | |
| CN105566314B (zh) | 一种盐酸替扎尼定化合物 | |
| TW201247680A (en) | Amorphous N-benzoyl-staurosporine, processes for the preparation, and use thereof | |
| TW385250B (en) | Treating agent for diseases due to infection with helicobacter | |
| US3989746A (en) | Substituted naphthyl anthranilic acids | |
| CN104860847B (zh) | 利凡斯的明和咖啡酸、阿魏酸的二聚体,其制备方法及其药物组合物 | |
| JP2018537515A (ja) | フェンカンファミンのプロドラッグ | |
| CN106065016A (zh) | 一种周期素依赖性蛋白激酶抑制剂的结晶形式及其制备方法 | |
| JPS6242953A (ja) | １，１，２，２−テトラメチル−１，２−ビス−（フツ素−４−ヒドロキシ−フエニル）−エタンの新規誘導体、その製法およびこれを含有する抗癌剤 | |
| US8946474B2 (en) | Polymorphic form of a calcimimetic compound | |
| CN102670572A (zh) | 一种双-（2,3-二溴-4,5-二羟基苄基）醚的合成与应用 | |
| CN104211669B (zh) | 含笑内酯衍生物，及其制备方法和用途 | |
| CN100569740C (zh) | N-or酰胺类化合物,其制备方法和其应用 | |
| JP2022527279A (ja) | キノリン誘導体及び癌の治療のためのその使用 | |
| WO2015010666A2 (zh) | 一种苯酚衍生物及其应用 | |
| CN102666528A (zh) | 晶体cdc7 抑制剂盐 | |
| JPS6322069A (ja) | 複素多環式芳香族化合物 | |
| RU2802964C2 (ru) | Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида |